Edward Hammond

13.8k citations

164 papers · 10.3k indexed · 6 hit papers · h-index 55

Pulmonary and Respiratory Medicine top 0.5%
Molecular Biology top 5%
Cell Biology top 0.5%
Oncology top 2%
Health, Toxicology and Mutagenesis top 0.5%

Co-authors: Irving J. Selikoff Lawrence Garfinkel Oscar Auerbach Herbert Seidman Jacob Churg Arthur Purdy Stout Keith Dredge Vito Ferro
Topics: Proteoglycans and glycosaminoglycans research (27 papers)Glycosylation and Glycoproteins Research (19 papers)Occupational and environmental lung diseases (17 papers)
Cited by: Pulmonary and Respiratory Medicine Cell Biology Health, Toxicology and Mutagenesis
Journals: Science New England Journal of Medicine Proceedings of the National Academy of Sciences
Partner nations: United States Australia Israel

In The Last Decade

Edward Hammond

159 papers receiving 8.8k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Smoking and Lung Cancer: Recent Evidence and a Discussion of Some Questions

1959 597 citations Edward Hammond et al. profile →
Asbestos Exposure and Neoplasia

1964 489 citations Irving J. Selikoff, Edward Hammond et al. profile →
MORTALITY EXPERIENCE OF INSULATION WORKERS IN THE UNITED STATES AND CANADA, 1943‐1976*

1979 469 citations Irving J. Selikoff, Edward Hammond et al. profile →
Changes in Bronchial Epithelium in Relation to Cigarette Smoking and in Relation to Lung Cancer

1961 469 citations Edward Hammond et al. profile →
SMOKING AND DEATH RATES—REPORT ON FORTY-FOUR MONTHS OF FOLLOW-UP OF 187,783 MEN

1958 420 citations Edward Hammond profile →
ASBESTOS EXPOSURE, CIGARETTE SMOKING AND DEATH RATES*

1979 403 citations Edward Hammond, Irving J. Selikoff et al. profile →

Peers

Countries citing papers authored by Edward Hammond

Since Specialization

Citations

This map shows the geographic impact of Edward Hammond's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward Hammond with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward Hammond more than expected).

Fields of papers citing papers by Edward Hammond

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edward Hammond. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward Hammond. The network helps show where Edward Hammond may publish in the future.

Co-authorship network of co-authors of Edward Hammond

This figure shows the co-authorship network connecting the top 25 collaborators of Edward Hammond. A scholar is included among the top collaborators of Edward Hammond based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edward Hammond. Edward Hammond is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	PG545 sensitizes ovarian cancer cells to PARP inhibitors through modulation of RAD51-DEK interaction 2023 ·Oncogene ·Upasana Ray,Prabhu Thirusangu,Ling Jin,Yinan Xiao,(unknown),Julie Staub,Courtney L. Erskine,Keith Dredge,Edward Hammond,Matthew S. Block,Scott H. Kaufmann,Jamie N. Bakkum‐Gamez,Viji Shridhar	7
2	Evidence of a putative glycosaminoglycan binding site on the glycosylated SARS-CoV-2 spike protein N-terminal domain 2021 ·Computational and Structural Biotechnology Journal ·(unknown),Edward Hammond,Stefano Elli,Timothy R. Rudd,Courtney J. Mycroft‐West,Marcelo A. Lima,Mark A. Skidmore,Richard Karlsson,Yen‐Hsi Chen,Ieva Bagdonaite,Zhang Yang,Yassir Ahmed,Derek J. Richard,Jeremy E. Turnbull,Vito Ferro,Deirdre R. Coombe,Neha S. Gandhi	34
3	Heparanase Inhibition by Pixatimod (PG545): Basic Aspects and Future Perspectives 2020 ·Advances in experimental medicine and biology ·Edward Hammond,Keith Dredge	12
4	Immunomodulatory activities of pixatimod: emerging nonclinical and clinical data, and its potential utility in combination with PD-1 inhibitors 2018 ·Journal for ImmunoTherapy of Cancer ·Edward Hammond,Nicole M. Haynes,Carleen Cullinane,Todd V. Brennan,(unknown),Paul Handley,Tomislav Karoli,(unknown),Liwen Lin,Yiping Yang,Keith Dredge	35
5	Inhibition of Heparanase in Pediatric Brain Tumor Cells Attenuates their Proliferation, Invasive Capacity, and In Vivo Tumor Growth 2017 ·Molecular Cancer Therapeutics ·(unknown),Soumi Kundu,(unknown),Di Yu,Tommie Olofsson,Keith Dredge,Edward Hammond,Uri Barash,Israël Vlodavsky,Karin Forsberg‐Nilsson	30
6	Loss of HSulf-1: The Missing Link between Autophagy and Lipid Droplets in Ovarian Cancer 2017 ·Scientific Reports ·Debarshi Roy,Susmita Mondal,Ashwani Khurana,(unknown),Robert Hoffmann,Xiaoping He,Eleftheria Kalogera,Thomas Dierks,Edward Hammond,Keith Dredge,Viji Shridhar	15
7	Heparanase-neutralizing antibodies attenuate lymphoma tumor growth and metastasis 2016 ·Proceedings of the National Academy of Sciences ·Marina Weissmann,Gil Arvatz,Netanel A. Horowitz,Sari Feld,Inna Naroditsky,Yi Zhang,(unknown),Edward Hammond,Eviatar Nevo,Israël Vlodavsky,Neta Ilan	89
8	Heparanase Enhances Tumor Growth and Chemoresistance by Promoting Autophagy 2015 ·Cancer Research ·Anna Shteingauz,Ilanit Boyango,Inna Naroditsky,Edward Hammond,Maayan Gruber,Ilana Doweck,Neta Ilan,Israël Vlodavsky	130
9	Heparanase Cooperates with Ras to Drive Breast and Skin Tumorigenesis 2014 ·Cancer Research ·Ilanit Boyango,Uri Barash,Inna Naroditsky,Jin‐Ping Li,Edward Hammond,Neta Ilan,Israël Vlodavsky	61
10	Synthesis and Biological Evaluation of Polysulfated Oligosaccharide Glycosides as Inhibitors of Angiogenesis and Tumor Growth 2010 ·Journal of Medicinal Chemistry ·Ken D. Johnstone,Tomislav Karoli,Ligong Liu,Keith Dredge,(unknown),Cai Ping Li,Kat Davis,Edward Hammond,Ian Bytheway,Edmund Kostewicz,Francis C. K. Chiu,David M. Shackleford,Susan A. Charman,William N. Charman,Job Harenberg,Thomas J. Gonda,Vito Ferro	64
11	The Synthesis and Biological Evaluation of Two Analogues of the C-Riboside Showdomycin 2005 ·Australian Journal of Chemistry ·(unknown),(unknown),Beata Adamiak,Anthony C. Willis,Edward Hammond,Stephen Su,Christopher J. Burns,Edward Trybala,Vito Ferro,Martin G. Banwell	14
12	Closing loopholes in the biological weapons convention 2002 ·Medicine Conflict & Survival ·Jan van Aken,Edward Hammond	2
13	Toxicity of vinyl chloride-polyvinyl chloride 1975 ·New York Academy of Sciences eBooks ·Irving J. Selikoff,Edward Hammond	20
14	The epidemiological approach to the etiology of cancer 1975 ·Cancer ·Edward Hammond	3
15	Epidemiologic basis for cancer prevention 1974 ·Cancer ·Edward Hammond	1
16	Cancer Prevention and Competitive Risks 1969 ·Archives of Environmental Health An International Journal ·Edward Hammond	1
17	Smoking in Relation to Mortality and Morbidity. 1965 ·Edward Hammond	40
18	Inhalation of tobacco smoke. 1963 ·PubMed ·Edward Hammond	1
19	Smoking in Relation to Physical Complaints 1961 ·Archives of Environmental Health An International Journal ·Edward Hammond	45
20	Cancer Etiology: New Prospective Epidemiological Study 1959 ·CA A Cancer Journal for Clinicians ·Edward Hammond	6

About Edward Hammond

Edward Hammond is a scholar working on Cell Biology, Fuel Technology and Pulmonary and Respiratory Medicine, having authored 164 papers that have together received 10.3k indexed citations. Recurring topics across this work include Proteoglycans and glycosaminoglycans research (27 papers), Glycosylation and Glycoproteins Research (19 papers) and Occupational and environmental lung diseases (17 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (3.8k citations), Cell Biology (1.4k citations) and Health, Toxicology and Mutagenesis (1.2k citations). Edward Hammond has collaborated with scholars based in United States, Australia and Israel. Frequent co-authors include Irving J. Selikoff, Lawrence Garfinkel, Oscar Auerbach, Herbert Seidman, Jacob Churg, Arthur Purdy Stout, Keith Dredge, Vito Ferro, Jerome Cornfield and E. L. Wynder. Their work appears in journals such as Science, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact